Characterization of neurotransmitter phenotype during neuronal differentiation of embryonal carcinoma cells.
Embryonal carcinoma cells are useful in the study of embryogenesis and development, and their differentiation into neurons serves as a model of neuronal development. Retinoic acid was used to differentiate P19S18O1A1 embryonal carcinoma cells into neuronal, glial, and fibroblast-like cells and the phenotype of the neuronal population was examined. Neuron-specific enolase was present in the neuronal cells, suggesting that these neurons had reached some degree of maturity. A population (approximately 70%) of the neurons showed positive immunocytochemistry for tyrosine hydroxylase, dopamine beta-hydroxylase and phenylethanolamine N-methyltransferase, three enzymes in the pathway of catecholamine synthesis. Therefore a population of the neurons appeared to be adrenergic. These neurons also showed a low level of histofluorescence for endogenous catecholamines and exhibited an exogenous catecholamine reuptake system. In order to determine the phenotype of other neuron-like cells found to be negative for the adrenergic properties examined, immunocytochemistry for neuropeptides and neurotransmitters known to coexist within central neurons was performed. Serotonin, vasoactive intestinal peptide, glutamic acid decarboxylase, and choline acetyltransferase were all absent from retinoic acid-treated P19S18O1A1 neuronal cultures. These studies, along with those that compare the effects of retinoic acid and other growth modulators on neuronal differentiation of embryonal carcinoma cells, should aid in the understanding of neuronal induction and development in vivo.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D007381:Intermediate Filament Proteins / Q000032:analysis; D051379:Mice; D009363:Neoplasm Proteins / Q000032:analysis; D016900:Neurofilament Proteins; D009474:Neurons; D018377:Neurotransmitter Agents / Q000032:analysis*; D010641:Phenotype; D013724:Teratoma / Q000032:analysis / Q000473:pathology*; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000032:analysis / Q000187:drug effects / Q000473:pathology
D002395:Catecholamines; D007381:Intermediate Filament Proteins; D009363:Neoplasm Proteins; D016900:Neurofilament Proteins; D018377:Neurotransmitter Agents; D014212:Tretinoin